Association of Neuropeptide Y Gene rs16147 Polymorphism with Cardiovascular Risk Factors, Adipokines, and Metabolic Syndrome in Patients with Obesity

被引:9
作者
Antonio de Luis, Daniel
Izaola, Olatz
de la Fuente, Beatriz
Primo, David
Aller, Rocio
机构
[1] Univ Valladolid, Ctr Invest Endocrinol & Nutr, Sch Med, Hosp Clin Univ, Valladolid, Spain
[2] Univ Valladolid, Dept Endocrinol & Nutr, Hosp Clin Univ, Valladolid, Spain
关键词
Rs16147; NPY gene; Single-nucleotide polymorphisms; Adipokines; Metabolic syndrome; PROMOTER POLYMORPHISM; NPY GENE; DIET; ADIPONECTIN; VARIANTS; RECEPTOR; WEIGHT; LEPTIN;
D O I
10.1159/000452131
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background and Aims: The NPY gene has 4 exons, and it is located at 7p15.1. The main genetic variant described in this gene is rs16147. The aim of this study was to investigate the relationship of NPY rs16147 with body weight, insulin resistance, serum adipokine levels, and risk of metabolic syndrome (MetS). Methods: A population of 1,005 obese patients was analyzed in a cross-sectional survey. Weight, fat mass, waist circumference, blood pressure, basal glucose, C-reactive protein, insulin, insulin resistance (homeostasis model assessment of insulin resistance [HOMA-IR]), lipid profile, and adipocytokine (leptin, adiponectin, and resistin) levels were measured. The genotype of the NPY gene polymorphism (rs16147) was studied. Results: Body mass index (1.0 +/- 0.1; p < 0.05), weight (2.8 +/- 0.4 kg; p < 0.05), fat mass (1.8 +/- 0.3 kg; p < 0.05), waist circumference (1.9 +/- 0.2 cm; p < 0.05), leptin level (15.4 +/- 8.2 ng/mL; p < 0.05), insulin level (5.1 +/- 1.3 mIU/L; p < 0.05), and HOMA-IR (1.4 +/- 0.1 units; p < 0.05) were lower in A allele carriers than in non-A allele carriers in males. Males with an A allele had a lower percentage of MetS (54.8 vs. 69.1%; p < 0.05), central obesity (94.5 vs. 100%; p < 0.05), and hyperglycemia (24.7 vs. 33.8%; p < 0.05) than non-A allele carriers. Logistic regression analysis indicated that male non-A allele carriers had an increased risk of MetS (odds ratio [OR] = 1.26, 95% confidence interval [CI] = 1.17-1.83; p = 0.034), an increased risk of central obesity (OR = 1.08, 95% CI = 1.02-1.11; p = 0.044), and an increased risk of hyperglycemia (OR = 1.20, 95% CI = 1.09-1.79; p = 0.028) after adjusting for age. Conclusions: In obese males, the rs164147 polymorphism of the NPY gene is associated with leptin, insulin level, HOMA-IR, and an increased risk of MetS and its related phenotypes, such as central obesity and hyperglycemia. (C) 2016 S. Karger AG, Basel
引用
收藏
页码:213 / 221
页数:9
相关论文
共 25 条
[1]   Genetic variation may influence obesity only under conditions of diet: Analysis of three candidate genes [J].
Aberle, Jens ;
Fitsch, Jorg ;
Beck, Nicola Alessia ;
Mann, Oliver ;
Busch, Philipp ;
Peitsmeier, Philipp ;
Beil, Frank Ulrich .
MOLECULAR GENETICS AND METABOLISM, 2008, 95 (03) :188-191
[2]   Association studies of BMI and type 2 diabetes in the neuropeptide y pathway -: A possible role for NPY2R as a candidate gene for type 2 diabetes in men [J].
Campbell, Catarina D. ;
Lyon, Helen N. ;
Nemesh, James ;
Drake, Jared A. ;
Tuomi, Tiinamaija ;
Gaudet, Daniel ;
Zhu, Xiaofeng ;
Cooper, Richard S. ;
Ardlie, Kristin G. ;
Groop, Leif C. ;
Hirschhorn, Joel N. .
DIABETES, 2007, 56 (05) :1460-1467
[3]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[4]   Chromosome 4q31-34 panic disorder risk locus:: Association of neuropeptide YY5 receptor variants [J].
Domschke, Katharina ;
Hohoff, Christa ;
Jacob, Christian ;
Maier, Wolfgang ;
Fritze, Juergen ;
Bandelow, Borwin ;
Krakowitzky, Petra ;
Kaestner, Florian ;
Rothermundt, Matthias ;
Arolt, Volker ;
Deckert, Juergen .
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2008, 147B (04) :510-516
[5]   The Subgenual Anterior Cingulate Cortex in Mood Disorders [J].
Drevets, Wayne C. ;
Savitz, Jonathan .
CNS SPECTRUMS, 2008, 13 (08) :663-681
[6]   Validation of a Kinetic Model for the Reactions in RIA [J].
Duart Duart, Maria J. ;
Olivas Arroyo, Consuelo ;
Moreno Frigols, Jose Luis .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (11) :1161-1167
[7]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[8]   Increasing association between a neuropeptide Y promoter polymorphism and body mass index during the course of development [J].
Hohmann, S. ;
Buchmann, A. F. ;
Witt, S. H. ;
Rietschel, M. ;
Jennen-Steinmetz, C. ;
Schmidt, M. H. ;
Esser, G. ;
Banaschewski, T. ;
Laucht, M. .
PEDIATRIC OBESITY, 2012, 7 (06) :453-460
[9]  
Kelishadi R., 2008, Eastern Mediterranean Health Journal, V14, P1070
[10]   Association of the C-399T promoter polymorphism of neuropeptide Y with susceptibility to ischemic stroke [J].
Kim, No S. ;
Oh, Se-Mi ;
Ko, Mi M. ;
Cha, Min H. ;
Kang, Byoung K. ;
Bang, Ok S. .
CLINICAL BIOCHEMISTRY, 2009, 42 (16-17) :1699-1704